Literature DB >> 12508089

Nicotinic induction of preproenkephalin and tyrosine hydroxylase gene expression in butyrate-differentiated rat PC12 cells: a model for adaptation to gut-derived environmental signals.

Bistra B Nankova1, Jennifer Chua, Ravi Mishra, Catherine D Kobasiuk, Edmund F La Gamma.   

Abstract

Accelerated maturation of peripheral sympathoadrenal transmitter levels and function occurs at 7-10 postnatal days in the rat. This event is temporally disconnected from the timing of major changes in physiologic stimuli evident after the birthing process (i.e. temperature, oxygen, sound, light, etc.). Colonization of the gut, fermentation of carbohydrates, and production of short-chain fatty acids (e.g. butyrate) mirrors this postnatal time course. In this report, we examined the interaction between butyrate differentiation of rat pheochromocytoma cells and cholinergic-nicotinic induction of the neuropeptide (enkephalin) and catecholamine-related biosynthetic enzymes (tyrosine hydroxylase, dopamine beta-hydroxylase, phenylethanolamine N-methyltransferase). Our results show that butyrate induces both preproenkephalin and tyrosine hydroxylase mRNA through a proximal promoter region and that this regulatory step is time and dose dependent. Moreover, there is an additional interaction with cholinergic-nicotinic inducible mechanisms consistent with classically described transsynaptic cholinergic regulation of these genes. Dopamine beta-hydroxylase and phenylethanolamine N-methyltransferase promoters were not affected by butyrate treatment. We speculate that colonization of the human gut (along with the attendant fermentation of enteral carbohydrates to short-chain fatty acids) may represent a mechanism through which environmental signals affect postnatal maturation of sympathoadrenal transmitter systems.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12508089     DOI: 10.1203/00006450-200301000-00019

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  5 in total

1.  Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson's disease.

Authors:  R St Laurent; L M O'Brien; S T Ahmad
Journal:  Neuroscience       Date:  2013-04-25       Impact factor: 3.590

2.  Partial blockade of nicotinic acetylcholine receptors improves the counterregulatory response to hypoglycemia in recurrently hypoglycemic rats.

Authors:  Edmund F LaGamma; Necla Kirtok; Owen Chan; Bistra B Nankova
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-12       Impact factor: 4.310

3.  Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers.

Authors:  Luying Peng; Zhong-Rong Li; Robert S Green; Ian R Holzman; Jing Lin
Journal:  J Nutr       Date:  2009-07-22       Impact factor: 4.798

4.  Enteric bacterial metabolites propionic and butyric acid modulate gene expression, including CREB-dependent catecholaminergic neurotransmission, in PC12 cells--possible relevance to autism spectrum disorders.

Authors:  Bistra B Nankova; Raj Agarwal; Derrick F MacFabe; Edmund F La Gamma
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

5.  A prebiotic intervention study in children with autism spectrum disorders (ASDs).

Authors:  Roberta Grimaldi; Glenn R Gibson; Jelena Vulevic; Natasa Giallourou; Josué L Castro-Mejía; Lars H Hansen; E Leigh Gibson; Dennis S Nielsen; Adele Costabile
Journal:  Microbiome       Date:  2018-08-02       Impact factor: 14.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.